Management of malignant blood diseases with compound E39.
D000970:Antineoplastic Agents / Q000628:therapy*; D001388:Aziridines; D019468:Disease Management; D006402:Hematologic Diseases / Q000628:therapy*; D006801:Humans
D000970:Antineoplastic Agents; D001388:Aziridines; C026480:inproquone
ANTINEOPLASTIC AGENTS/therapy; BLOOD DISEASES/therapy